Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays ; volume:40 ; number:10 ; day:25 ; month:10 ; year:2023 ; pages:2383-2397 ; date:10.2023
Pharmaceutical research ; 40, Heft 10 (25.10.2023), 2383-2397, 10.2023
- Creator
-
Butala-Flores, Elizabeth
Nguyen, Thien
Selvan, Nithya
Armstrong, Luke
Miller, Michelle
Kamen, Lynn
Lester, Todd
Wernyj, Roman
Khanna, Richie
McNally, Jim
Hays, Amanda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-023-03625-7
- URN
-
urn:nbn:de:101:1-2024020809175885805965
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Butala-Flores, Elizabeth
- Nguyen, Thien
- Selvan, Nithya
- Armstrong, Luke
- Miller, Michelle
- Kamen, Lynn
- Lester, Todd
- Wernyj, Roman
- Khanna, Richie
- McNally, Jim
- Hays, Amanda
- SpringerLink (Online service)
Other Objects (12)
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Analysis of infection relevant protein domains of the adeno-associated virus serotype 8 in comparison to serotype 2
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Adeno-associated virus serotype 2 capsids with proteolytic cuts by trypsin remain intact and potent
A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Analysis of infection relevant protein domains of the adeno-associated virus serotype 8 in comparison to serotype 2
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Adeno-associated virus serotype 2 capsids with proteolytic cuts by trypsin remain intact and potent
A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Analysis of infection relevant protein domains of the adeno-associated virus serotype 8 in comparison to serotype 2
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Adeno-associated virus serotype 2 capsids with proteolytic cuts by trypsin remain intact and potent
A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity